Sylvia E. Rosas
Impact in
- Nephrology top 0.05%
- Parathyroid Disorders and Treatments
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Renal Diseases and Glomerulopathies
- Transplantation top 0.5%
- Renal Transplantation Outcomes and Treatments
Papers in
- Nephrology 54
- Chronic Kidney Disease and Diabetes 31
- Dialysis and Renal Disease Management 13
- Parathyroid Disorders and Treatments 10
- Renal Diseases and Glomerulopathies 8
-
- Diabetes Treatment and Management 15
- Diabetes Management and Research 9
- Co-authors
- Peter R Rossing (13 shared papers)Harold I. Feldman (23 shared papers)Chantal Mathieu (3 shared papers)Vanita R. Aroda (2 shared papers)Stefano Del Prato (2 shared papers)Nisa M. Maruthur (2 shared papers)Robert A. Gabbay (2 shared papers)Billy S. Collins (2 shared papers)
- Journals
- Diabetes Care (27 papers)American Journal of Kidney Diseases (17 papers)Journal of the American Society of Nephrology (13 papers)Kidney International (12 papers)Clinical Journal of the American Society of Nephrology (9 papers)
- Partner nations
- United StatesDenmarkGermany
In The Last Decade
Sylvia E. Rosas
184 papers receiving 11.9k citations
Sylvia E. Rosas's Hit Papers
Peers
Comparison fields: 5 of 147
- Nephrology 4.4k
- Transplantation 446
- Endocrinology, Diabetes and Metabolism 2.6k
- Cardiology and Cardiovascular Medicine 1.2k
- Emergency Medical Services 322
Countries citing papers authored by Sylvia E. Rosas
This map shows the geographic impact of Sylvia E. Rosas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia E. Rosas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia E. Rosas more than expected).
Fields of papers citing papers by Sylvia E. Rosas
This network shows the impact of papers produced by Sylvia E. Rosas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia E. Rosas. The network helps show where Sylvia E. Rosas may publish in the future.
Co-authors
The 25 scholars most cited alongside Sylvia E. Rosas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FGF23 induces left ventricular hypertrophy Hit paper breakdown → | 2011 | 1684 |
| 2 | Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2022 | 1216 |
| 3 | Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Hit paper breakdown → | 2022 | 664 |
| 4 | Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) Hit paper breakdown → | 2022 | 541 |
| 5 | Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function Hit paper breakdown → | 2016 | 426 |
| 6 | An atlas of healthy and injured cell states and niches in the human kidney Hit paper breakdown → | 2023 | 394 |
| 7 | 2017 | 285 | |
| 8 | 2017 | 284 | |
| 9 | Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes Hit paper breakdown → | 2020 | 282 |
| 10 | 2012 | 249 | |
| 11 | 2018 | 233 | |
| 12 | Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) Hit paper breakdown → | 2022 | 225 |
| 13 | 2003 | 206 | |
| 14 | 2015 | 191 | |
| 15 | Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis Hit paper breakdown → | 2022 | 167 |
| 16 | 2005 | 166 | |
| 17 | 2001 | 158 | |
| 18 | 2020 | 155 | |
| 19 | 2015 | 127 | |
| 20 | 2013 | 125 |
About Sylvia E. Rosas
Sylvia E. Rosas is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Transplantation, Cardiology and Cardiovascular Medicine and Emergency Medical Services, having authored 187 papers that have together received 12.4k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (31 papers), Diabetes Treatment and Management (15 papers), Renal Transplantation Outcomes and Treatments (13 papers), Dialysis and Renal Disease Management (13 papers), Parathyroid Disorders and Treatments (10 papers), Diabetes Management and Research (9 papers), Blood Pressure and Hypertension Studies (8 papers) and Renal Diseases and Glomerulopathies (8 papers). The work is most often cited by research in Nephrology (4.4k citations), Transplantation (446 citations), Endocrinology, Diabetes and Metabolism (2.6k citations), Cardiology and Cardiovascular Medicine (1.2k citations) and Emergency Medical Services (322 citations). Sylvia E. Rosas has collaborated with scholars based in United States, Denmark and Germany. Frequent co-authors include Peter R Rossing, Harold I. Feldman, Chantal Mathieu, Vanita R. Aroda, Stefano Del Prato, Nisa M. Maruthur, Robert A. Gabbay, Billy S. Collins, Geltrude Mingrone and Melanie J. Davies. Their work appears in journals such as Diabetes Care, American Journal of Kidney Diseases, Journal of the American Society of Nephrology, Kidney International and Clinical Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.